An	O
autoregulatory	B-ENHANCER
enhancer	E-ENHANCER
controls	O
mammary	O
-	O
specific	O
STAT5	O
functions	O
.	O


Signal	O
Transducers	O
and	O
Activators	O
of	O
Transcription	O
(	O
STATs	O
)	O
are	O
principal	O
transcription	O
factors	O
downstream	O
of	O
cytokine	O
receptors	O
.	O


Although	O
STAT5A	O
is	O
expressed	O
in	O
most	O
tissues	O
it	O
remains	O
to	O
be	O
understood	O
why	O
its	O
premier	O
,	O
non	O
-	O
redundant	O
functions	O
are	O
restricted	O
to	O
prolactin	O
-	O
induced	O
mammary	O
gland	O
development	O
and	O
function	O
.	O


We	O
report	O
that	O
the	O
ubiquitously	O
expressed	O
Stat5a	O
/	O
b	O
locus	O
is	O
subject	O
to	O
additional	O
lineage	O
-	O
specific	O
transcriptional	O
control	O
in	O
mammary	O
epithelium	O
.	O


Genome	O
-	O
wide	O
surveys	O
of	O
epigenetic	O
status	O
and	O
transcription	O
factor	O
occupancy	O
uncovered	O
a	O
putative	O
mammary	B-ENHANCER
-	I-ENHANCER
specific	I-ENHANCER
enhancer	I-ENHANCER
within	I-ENHANCER
the	I-ENHANCER
intergenic	I-ENHANCER
sequences	I-ENHANCER
separating	I-ENHANCER
the	I-ENHANCER
two	I-ENHANCER
Stat5	I-ENHANCER
genes	E-ENHANCER
.	O


This	O
region	O
exhibited	O
several	O
hallmarks	O
of	O
genomic	O
enhancers	O
,	O
including	O
DNaseI	O
hypersensitivity	O
,	O
H3K27	O
acetylation	O
and	O
binding	O
by	O
GR	O
,	O
NFIB	O
,	O
ELF5	O
and	O
MED1	O
.	O


Mammary	O
-	O
specific	O
STAT5	O
binding	O
was	O
obtained	O
at	O
two	O
canonical	O
STAT5	O
binding	O
motifs	O
.	O


CRISPR	O
/	O
Cas9	O
-	O
mediated	O
genome	O
editing	O
was	O
used	O
to	O
delete	O
these	O
sites	O
in	O
mice	O
and	O
determine	O
their	O
biological	O
function	O
.	O


Mutant	O
animals	O
exhibited	O
an	O
80	O
%	O
reduction	O
of	O
Stat5	O
levels	O
in	O
mammary	O
epithelium	O
and	O
a	O
concomitant	O
reduction	O
of	O
STAT5	O
-	O
dependent	O
gene	O
expression	O
.	O


Transcriptome	O
analysis	O
identified	O
a	O
class	O
of	O
mammary	O
-	O
restricted	O
genes	O
that	O
was	O
particularly	O
dependent	O
on	O
high	O
STAT5	O
levels	O
as	O
a	O
result	O
of	O
the	O
intergenic	B-ENHANCER
enhancer	E-ENHANCER
.	O


Taken	O
together	O
,	O
the	O
mammary	B-ENHANCER
-	I-ENHANCER
specific	I-ENHANCER
enhancer	E-ENHANCER
enables	O
a	O
positive	O
feedback	O
circuit	O
that	O
contributes	O
to	O
the	O
remarkable	O
abundance	O
of	O
STAT5	O
and	O
,	O
in	O
turn	O
,	O
to	O
the	O
efficacy	O
of	O
STAT5	O
-	O
dependent	O
mammary	O
physiology	O
.	O
